Rare diseases
Investigational molecules
Locations
Back to Belgium121 clinical trials in Sint-Niklaas, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
BelgiumStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
BelgiumA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
BelgiumA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
BelgiumA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BelgiumA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
BelgiumA study testing duvakitug for patients with moderately to severely active ulcerative colitis
BelgiumStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
BelgiumStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
BelgiumStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
BelgiumStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
BelgiumStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on lung cancer treatments, including both small cell and non-small cell variants. Multiple trials evaluating novel combination therapies with chemotherapy and immunotherapy agents.
Studies include evaluation of targeted therapies for specific cancer mutations and biomarkers.
Clinical investigations focusing on inflammatory bowel conditions, including Crohn's disease and ulcerative colitis. Trials evaluating new therapeutic approaches for disease management.
Research emphasizes both therapeutic intervention and disease monitoring strategies.
Studies examining treatments for coronary artery disease and stroke prevention in patients with atrial fibrillation. Trials evaluating novel anticoagulation approaches.
Focus on both preventive measures and post-intervention care strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
